title=USPMG (USP Model Guidelines) - Synopsis
date=2017-11-06
updated=2020-11-02
type=page
status=published
~~~~~~


<!--menu-->
<div class="row">
 <div class="container-fluid navbar navbar-default vocab-docs-navbar" role="navigation">
  <div class="btn-group navbar-btn visible-*" role="group">
   <a class="btn btn-md" role="button" href="index.html">Synopsis</a>
   <a class="btn btn-md" role="button" href="metadata.html">Metadata</a>
   <a class="btn btn-md" role="button" href="stats.html">Statistics</a>
   <a class="btn btn-md" role="button" href="sourcerepresentation.html">Source Representation</a>
   <a class="btn btn-md" role="button" href="metarepresentation.html">Metathesaurus Representation</a>
  </div>
 </div>
</div>
<!--endmenu-->
<br/>
<div id="summary">


 <p><b>Web site</b><br />
 <a href=
 "http://www.usp.org/health-quality-safety/usp-medicare-model-guidelines">http://www.usp.org/health-quality-safety/usp-medicare-model-guidelines</a></p>
 <p><b>Authority</b><br />
 The Medicare Model Guidelines were developed and are
 maintained by the U.S. Pharmacopeial Convention (USP) in
 conjunction with the Centers for Medicare and Medicaid Services
 (CMS).</p>
 <p><b>Purpose</b><br />
 Medicare Model Guidelines were developed as a result of the
 Medicare Prescription Drug, Improvement, and Modernization Act of
 2003 (MMA) to provide categories and classes of drugs covered by
 Medicare Part D.</p>
 <p><b>Description</b><br />
 Drugs are organized hierarchically by pharmacologic class
 within therapeutic categories. Drugs are grouped by drug type within the pharmacologic
 classes.</p>
 <p><b>Audience</b><br />
 Medicare Model Guidelines are used by CMS, Medicare
 beneficiaries, and Part D drug plan companies.</p>
 <p><b>Update Frequency</b><br />
 Medicare Model Guidelines are updated every three years.</p>
<!-- <p><b>Metathesaurus Update Frequency</b><br />
 Medicare Model Guidelines were last updated in the
 Metathesaurus in 2014.</p>-->
 <p><b>Sites Consulted</b></p>
 <ol>
 <li>Medicare Model Guidelines [Internet]. Rockville (MD): The
 United States Pharmacopeial Convention; c2010 [cited 2010 Apr 1].
 Available from: http://www.usp.org/hqi/mmg/.</li>
 <li>Dill G. Medicare Prescription Drug Benefit: Summary of USP
 approach and methodology to the Model Guidelines Version 4.0
 [Internet]. Rockville (MD): The United States Pharmacopeial
 Convention; c2010 [cited 2010 Apr 5]. 19 p. Available from:
 
 http://www.usp.org/pdf/EN/mmg/modelGuidelinesV4SummaryOfApproach.pdf</li>
 </ol>


 </div>
